1,102 reports of this reaction
4.5% of all VALGANCICLOVIR HYDROCHLORIDE POWDER, reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for VALGANCICLOVIR HYDROCHLORIDE POWDER,, manufactured by Ajanta Pharma USA Inc.. There are 1,102 FDA adverse event reports linking VALGANCICLOVIR HYDROCHLORIDE POWDER, to DRUG INEFFECTIVE. This represents approximately 4.5% of all 24,571 adverse event reports for this drug.
Patients taking VALGANCICLOVIR HYDROCHLORIDE POWDER, who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among VALGANCICLOVIR HYDROCHLORIDE POWDER, users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for VALGANCICLOVIR HYDROCHLORIDE POWDER,:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,102 FDA reports for VALGANCICLOVIR HYDROCHLORIDE POWDER,. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 4.5% of all adverse event reports for VALGANCICLOVIR HYDROCHLORIDE POWDER,, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking VALGANCICLOVIR HYDROCHLORIDE POWDER,, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.